Adaptive Innovations
8 known investors
Adaptive is an AI-native healthcare provider that delivers home health services by combining artificial intelligence-driven operations with in-home clinicians to improve patient outcomes and reduce hospital readmissions.
Also known as Adaptive · Adaptive Innovations
Founders & leadership

Investors · 8
Also in the syndicate · 2
Funding
SEC filings, press & company announcements$50M disclosed across 1 of 2 rounds · 2026
- $50MSeries AJun 2026 · 4 sources
Felicis (lead), Bain Capital Ventures, BoxGroup, Constellation, Conviction, Dorm Room Fund, Optum Ventures, Sunflower Capital, SV Angel
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Company profile
researched Aug 2026Adaptive Innovations is an AI-native healthcare provider that operates as a full-stack, vertically integrated home health agency rather than as a software vendor. The company pairs clinicians delivering in-person care in patients' homes with an AI operating system that runs the surrounding administrative chain: intake, scheduling, prior authorization, charting, coding, billing and compliance. Its stated premise is that coordination overhead — cited at $0.60 to $0.90 for every $1 of clinical labor, and 40-50% of home health spending — causes agencies to reject an estimated $40B in referrals annually, leaving roughly 40% (two in five) of referred patients without care.
By automating that overhead, Adaptive says it can profitably accept referrals that legacy agencies decline, including patients outside the traditional Medicare book of business; the company states only about a quarter of its patients are on traditional Medicare, versus an industry norm of roughly 80%. The company describes home health as the coordination layer for post-acute care and states an intent to extend into adjacent verticals such as home infusion, dialysis, durable medical equipment, hospice and specialty pharmaceuticals as patient density grows.
The founding team is Co-CEOs Alex Wendland and Logan Stinson, CTO Ryan Tolsma and COO Hunter Stinson. Wendland and Tolsma approached home health from an AI perspective; Logan Stinson has home health operating experience in Texas, and Hunter Stinson is a former nurse and U.S. Army Ranger officer. The broader team is described as engineers and operators from Scale AI, Palantir, Jane Street, Citadel and the U.S. Army Rangers.
Founding story
Alex Wendland and Ryan Tolsma initially examined home health through an AI lens and attempted to sell back-office streamlining software to existing agencies, but found the agencies too entrenched to adopt redesigned workflows, leaving the underlying economics of which patients got treated unchanged. They concluded the leverage was in becoming the provider rather than selling tools to providers, and built a home health company with AI embedded in the administrative chain from the start, adding operators Logan Stinson, who had scaled home health operations in Texas, and Hunter Stinson, a former nurse and U.S. Army Ranger officer.
Business model
Adaptive is the provider of record rather than a software vendor, earning revenue from delivering home health visits reimbursed by payers, including traditional Medicare, Medicare Advantage and commercial plans. Because AI removes most administrative cost, the company says it earns a wider margin per visit than a traditional agency and can accept referrals that would be uneconomic for legacy providers. It describes a physical network flywheel: more accepted patients increase geographic density, which reduces clinician drive time and raises clinician productivity and pay, which deepens health-system referral relationships. The company also states an intent to pursue outcomes-aligned contracting models with payers as scale increases.
Fee-for-service reimbursement for home health visits from payers; the company notes traditional Medicare pays roughly two to three times what Medicare Advantage and commercial plans pay for the same visit, and that its lower admin cost makes lower-reimbursement patients viable. Future payer partnerships on outcomes-based contracting are described as a plan, not current practice.
Traction
Since launching in 2025: over 100,000 patient visits delivered, 500+ referring healthcare organizations, 24/7 clinical coverage across five Texas regions, and referral relationships with every major Texas hospital system. Reported outcomes include a 4.9% rehospitalization rate, over 95% of patients improving in ambulation, 99% admitted within 48 hours of referral, a 4.5-star CMS rating, and approximately 80% less clinician documentation time.
Latest developments
On June 2, 2026 Adaptive Innovations announced a $50M Series A led by Felicis and Bain Capital Ventures, disclosed a prior $10M seed round, and stated that proceeds will grow engineering and operations teams, accelerate software development and support expansion into new state markets. Stated six-month milestone is multi-state expansion.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
Positioned as the first AI-native home health provider and, by its own account and that of its lead investor, already one of the largest home health providers in Texas. It differentiates from healthtech software vendors and telehealth by owning physical care delivery. The addressable market is described as home health at over $100B (elsewhere cited as $140B industry size), one of the fastest-growing outpatient sectors and on pace to nearly double over five to six years, with a longer-term target of all post-acute care.
Operating as the licensed provider rather than a software supplier, with AI rebuilt into the operating model from the inside out; the resulting cost structure allows acceptance of referrals other agencies reject and a patient mix weighted away from traditional Medicare. Reported quality metrics — 4.9% rehospitalization versus a 12.9% Texas and 10.2% national average, over 95% ambulation improvement versus an 89.5% national average, 99% of patients admitted within 48 hours of referral, and a 4.5-star CMS quality rating versus an industry average near 3 — are cited as evidence of outcome advantages.
Technology
A proprietary AI operating system that automates the end-to-end administrative workflow around a home visit — intake, scheduling, prior authorization, documentation/charting, coding, billing and compliance — replacing the patchwork of manual workflows used by legacy agencies. The company reports clinicians spend roughly 80% less time on documentation as a result.
Go-to-market
Growth is driven by referral relationships with hospitals and health systems, positioned around reliably accepting every referred patient, combined with clinician recruitment. The company markets itself for inbound health-system partnerships and hiring through its website and used the June 2026 funding announcement for public launch.
Patients referred for skilled home health and post-acute care, particularly those turned away by traditional agencies; referral sources are hospital systems and other healthcare organizations, with 500+ referring organizations including every major Texas hospital system.
Geography
Offices in New York City and Dallas, Texas; clinical operations across five regions of Texas with 24/7 coverage. The Series A is intended to fund expansion into additional U.S. states.
History
The company launched quietly in 2025 and by mid-2026 described itself as one of the largest home health providers in Texas, with 24/7 clinical coverage across five Texas regions and referral relationships with every major hospital system in the state. On June 2, 2026 it emerged publicly, announcing a $50M Series A alongside a previously undisclosed $10M seed round, bringing total funding to $60M.
Risks & controversies
Reported operating and outcome metrics (visit volume, rehospitalization rate, documentation time savings, CMS rating) originate from the company or its lead investor and are not independently verified in the sources. The business depends on payer reimbursement levels and on maintaining margin advantages from automation, and the company itself notes that investors are still learning how to evaluate AI-enabled service businesses. Operations are currently concentrated in Texas, and multi-state expansion is unproven. Source [6] attributes founding solely to Ryan Tolsma, which conflicts with other sources naming four cofounders. A separate IT services firm at adaptive-innovations.com shares the name but is unrelated.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Competitors · 4
by search overlapCompanies competing with Adaptive Innovations for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline · 3
launches, deals, and filingsThe company emerged publicly with a $50M Series A led by Felicis and Bain Capital Ventures, plus a previously undisclosed $10M seed round led by Bain Capital Ventures, bringing total funding to $60M. Funds are earmarked for engineering and operations hiring, software development, and expansion into new states.
$50M source ↗
Company states the Series A will fund territorial expansion into new state markets beyond Texas within roughly six months.
The company began delivering home health services in 2025, initially in Texas.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
▸Research sources · 8
primary sources listed
- Adaptive Innovationsadaptive.co · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Adaptive Innovations do?
- AI-native home health provider combining automated back-office operations with in-home clinicians, starting in Texas.
- Who founded Adaptive Innovations?
- Adaptive Innovations was founded by Ronak Massand.
- Who are Adaptive Innovations's investors?
- Adaptive Innovations's investors include Bain Capital Ventures, Felicis Ventures, BoxGroup, Constellation, Conviction, Optum Ventures.
- How much funding has Adaptive Innovations raised?
- Adaptive Innovations has disclosed $50M raised across 1 of its 2 known rounds.


.jpeg)


